QT
XENE icon

Quantbot Technologies’s Xenon Pharmaceuticals XENE Stock Holding History

Quantbot Technologies’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.2K Buy
947
+785
+485% +$43.6K ﹤0.01% 1606
2026
Q1 		$9.42K Buy
+162
New +$7.46K ﹤0.01% 1540
2022
Q4 		– Sell
-1,300
Closed -$46K – 2170
2022
Q3 		$46K Buy
+1,300
New +$46.7K ﹤0.01% 1257

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quantbot Technologies's XENE Position: Q2 2026 in Review

Quantbot Technologies increased its Xenon Pharmaceuticals (XENE) stake by 485% in Q2 2026, buying an estimated $43.6K and bringing the position to 947 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Quantbot Technologies first reported a position in XENE in Q3 2022 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Quantbot Technologies held 947 shares of Xenon Pharmaceuticals worth $57.2K as of Q2 2026.
  • Quantbot Technologies bought 785 Xenon Pharmaceuticals shares in Q2 2026, an estimated $43.6K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1606 holding.
  • Quantbot Technologies first reported a position in Xenon Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.